These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32627972)

  • 1. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
    Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
    Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
    Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
    Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.
    Chou WC; Lin Z
    Toxicol Sci; 2023 Jan; 191(1):1-14. PubMed ID: 36156156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice.
    Chou WC; Chen Q; Yuan L; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE; Lin Z
    J Control Release; 2023 Sep; 361():53-63. PubMed ID: 37499908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
    Hayat H; Nukala A; Nyamira A; Fan J; Wang P
    Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning and Artificial Intelligence in Toxicological Sciences.
    Lin Z; Chou WC
    Toxicol Sci; 2022 Aug; 189(1):7-19. PubMed ID: 35861448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence to bring nanomedicine to life.
    Serov N; Vinogradov V
    Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.
    Lin Z; Chou WC; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE
    Int J Nanomedicine; 2022; 17():1365-1379. PubMed ID: 35360005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence.
    Zaslavsky J; Bannigan P; Allen C
    Expert Opin Drug Deliv; 2023 Feb; 20(2):241-257. PubMed ID: 36644850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence.
    Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG
    Front Digit Health; 2022; 4():799341. PubMed ID: 35252958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
    Qi X; Zhao Y; Qi Z; Hou S; Chen J
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
    Mozafari N; Mozafari N; Dehshahri A; Azadi A
    Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases.
    Bakrania A; Joshi N; Zhao X; Zheng G; Bhat M
    Pharmacol Res; 2023 Mar; 189():106706. PubMed ID: 36813095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
    Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
    ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying artificial intelligence and computational modeling to nanomedicine.
    Hamilton S; Kingston BR
    Curr Opin Biotechnol; 2024 Feb; 85():103043. PubMed ID: 38091874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational pharmaceutics - A new paradigm of drug delivery.
    Wang W; Ye Z; Gao H; Ouyang D
    J Control Release; 2021 Oct; 338():119-136. PubMed ID: 34418520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling.
    Lin Z; Aryal S; Cheng YH; Gesquiere AJ
    ACS Nano; 2022 Dec; 16(12):19722-19754. PubMed ID: 36520546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.